BEYONDSPRING PHARMACEUTICALS
Spring Pharmaceuticals is a biotechnology company based in Duncan, South Carolina.
BEYONDSPRING PHARMACEUTICALS
Industry:
Biopharma Health Care Manufacturing Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.beyondspringpharma.com
Total Employee:
51+
Status:
Active
Contact:
+1-646-305-6387
Email Addresses:
[email protected]
Total Funding:
3.75 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Enlie Pharmaceutical
Enlie Pharmaceutical is a Vietnam-based pharmaceutical manufacturing company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Organic India
Organic India is a Pharmaceutical Manufacturing Company.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Sapala Organics
Sapala Organics is a pharmaceutical manufacturing company.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Investors List
Fang Fund Partners
Fang Fund Partners investment in Series A - BeyondSpring Pharmaceuticals
Xintong Capital
Xintong Capital investment in Series A - BeyondSpring Pharmaceuticals
Official Site Inspections
http://www.beyondspringpharma.com Semrush global rank: 4.09 M Semrush visits lastest month: 2.55 K
- Host name: ec2-54-88-217-202.compute-1.amazonaws.com
- IP address: 54.88.217.202
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "BeyondSpring Pharmaceuticals"
WHO WE ARE - beyondspringpharma.com
Headquartered in New Jersey, we are committed to raising the standard of care for cancer patients with first-in-class treatments that improve lives and clinical outcomes for millions of patients in need.See details»
Management Team | BeyondSpring
She currently serves as a board member of the Chinese Finance Association, a non-profit organization with over 6,000 members worldwide. A Chartered Financial Analyst, or CFA, Ms. Zhao holds an M.B.A. from Harvard Business …See details»
BeyondSpring Inc Company Profile | Management and Employees …
Company Name. BeyondSpring Inc. Main Industry. Research & Development, Business Services. Website. www.beyondspringpharma.comSee details»
BeyondSpring - LinkedIn
BeyondSpring | 5,337 followers on LinkedIn. BeyondSpring Pharmaceuticals is a global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes. The ...See details»
BeyondSpring Pharmaceuticals, Inc. - Drug pipelines, Patents, …
Www.beyondspringpharma.com. Subsidiary Company | New York, United States | www.beyondspringpharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. …See details»
BeyondSpring Pharmaceuticals - Crunchbase Company Profile
Organization. BeyondSpring Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
BeyondSpring Company Profile 2024: Stock Performance
Information on stock, financials, earnings, subsidiaries, investors, and executives for BeyondSpring. Use the PitchBook Platform to explore the full profile.See details»
BeyondSpring Company Overview, Contact Details & Competitors …
BeyondSpring Inc. launches data that translates preclinical proof-of-concept. NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) ("BeyondSpring" or …See details»
BeyondSpring Company Profile - Craft
Oct 16, 2024 BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. Its lead asset, plinabulin, is a selective …See details»
Board of Directors | BeyondSpring
Ravindra Majeti, M.D., co-founded Forty Seven and has served as a member of its Board of Directors since May 2015. Dr. Majeti served in various positions at Stanford University, including as a Professor in the Department of Medicine, …See details»
BeyondSpring Pharma - Company Profile - Tracxn
Oct 19, 2024 BeyondSpring Pharma - Combination therapies for patients suffering from non-small cell lung cancer.. Public Company. Raised funding over 2 rounds from 4 investors. …See details»
BeyondSpring - Overview, News & Similar companies - ZoomInfo
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics FLORHAM PARK, N.J., May 03, 2024 (GLOBE …See details»
BeyondSpring: Employee Directory | ZoomInfo.com
Feb 14, 2024 BeyondSpring Contact Info: Phone number: (646) 305-6387 Website: www.beyondspringpharma.com What does BeyondSpring do? BeyondSpring is a global, …See details»
Beyondspring Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Beyondspring Pharmaceuticals, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Beyondspring Inc, BYSI:NAQ profile - FT.com - Financial Times
BeyondSpring Inc. is a clinical-stage global biopharmaceutical company. The Company is focused on developing innovative therapies to improve clinical outcomes for patients with high unmet …See details»
Contact Us - BeyondSpring
[email protected] +1 (646) 305-6387. media and investor relations. [email protected]. [email protected]. Investor Contact …See details»
BeyondSpring Announces Oral Presentation at the 2024 World …
FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company …See details»
Pipeline - BeyondSpring
BeyondSpring Subsidiaries: 1) Dalian Wanchunbulin Pharmaceuticals Ltd., which owns China rights to Plinabulin, and 2) Seed Therapeutics, a target protein degradation company.See details»
NEWS & MEDIA | BeyondSpring
Nov 11, 2024 In 30 metastatic NSCLC patients who progressed on PD-1/PD-L1 inhibitors, the triple IO combo regimen at median follow-up time of 11.5 months achieved a DCR of 89.3% …See details»